Press Releases Latest May 02, 2024 Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO Meeting Press Releases Year None202420232022202120202019201820172016201520142013 Mar 29, 2018 Theratechnologies to Announce Financial Results for First Quarter 2018 Mar 08, 2018 New Positive Data on TROGARZO™ (ibalizumab-uiyk) injection and EGRIFTA® (tesamorelin for injection) Presented at 25th Conference on Retroviruses and Opportunistic Infections Mar 06, 2018 Theratechnologies Announces FDA Approval of Trogarzo Feb 07, 2018 Theratechnologies Announces Financial Results for Fiscal Year 2017 Jan 30, 2018 Theratechnologies to Announce Financial Results for Fiscal year 2017 Nov 13, 2017 Theratechnologies Announces Decision by the FDA to Extend the Ibalizumab Review Period to April 3, 2018 Oct 05, 2017 Theratechnologies Announces Financial Results For The Third Quarter Of 2017 Oct 04, 2017 Theratechnologies Announces 48-Week Efficacy and Safety Results for Ibalizumab Presented at IDWeek 2017™ Sep 25, 2017 TheraTechnologies to Announce Financial Results for the Third Quarter of 2017 Sep 18, 2017 IBALIZUMAB Long-Term Safety and Efficacy Data to be Presented at IDWEEK 2017 in SAN DIEGO First page « Previous page ‹ … Page 22 Page 23 Page 24 Page 25 Current page 26 Page 27 Page 28 Page 29 Page 30 … Next page › Last page » Displaying 251 - 260 of 361
May 02, 2024 Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO Meeting
Mar 08, 2018 New Positive Data on TROGARZO™ (ibalizumab-uiyk) injection and EGRIFTA® (tesamorelin for injection) Presented at 25th Conference on Retroviruses and Opportunistic Infections
Nov 13, 2017 Theratechnologies Announces Decision by the FDA to Extend the Ibalizumab Review Period to April 3, 2018
Oct 04, 2017 Theratechnologies Announces 48-Week Efficacy and Safety Results for Ibalizumab Presented at IDWeek 2017™
Sep 18, 2017 IBALIZUMAB Long-Term Safety and Efficacy Data to be Presented at IDWEEK 2017 in SAN DIEGO